𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: A population-based study in China

✍ Scribed by M. Patricia Madigan; Yu-Tang Gao; Jie Deng; Ruth M. Pfeiffer; Bao-Li Chang; Siqun Zheng; Deborah A. Meyers; Frank Z. Stanczyk; Jianfeng Xu; Ann W. Hsing

Publisher
John Wiley and Sons
Year
2003
Tongue
French
Weight
78 KB
Volume
107
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Because androgens likely play a key role in prostate growth and prostate cancer development, variants of genes involved in androgen biosynthesis may be related to prostate cancer risk. The enzyme P450c17α, encoded by the CYP17 gene, catalyzes the conversion of progesterone and pregnenolone into precursors of potent androgens. In the 5′ promoter region of the CYP17 gene, a T (A1 allele) to C substitution (A2 allele) has been hypothesized to increase CYP17 gene expression, resulting in higher levels of androgens. To investigate a possible role of CYP17 in prostate diseases, we evaluated the risk of prostate cancer and benign prostatic hyperplasia (BPH) in relation to variation in CYP17 genotype in a population‐based case‐control study conducted in Shanghai, China. The study included 174 prostate cancer cases, 182 BPH cases and 274 population controls. We observed no statistically significant overall associations of CYP17 genotypes with prostate cancer risk, although associations of the A1/A1 (odds ratio (OR) =1.42, 95% confidence interval (CI) 0.83–2.48) and A1/A2 (OR 1.41, 95% CI 0.91–2.17) genotypes with prostate cancer were suggested. A similar association of the A1/A1 genotype with BPH was suggested. We found no associations of CYP17 genotypes with serum sex hormone levels or other biomarkers after correction for multiple comparisons. Large population‐based studies are needed to clarify whether CYP17 plays a role in prostate cancer risk and whether genotype effects vary in different racial/ethnic and other subgroups. © 2003 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Prostate carcinoma risk subsequent to di
Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia : A population-based cohort study in Sweden
✍ Anand P. Chokkalingam; Olof Nyrén; Jan-Erik Johansson; Gloria Gridley; Joseph K. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract ## BACKGROUND Pathologically, benign prostatic hyperplasia (BPH) is not considered a precursor for prostate carcinoma. However, because the two conditions share not only a similar hormonal environment within the prostate but also several common risk factors, it is possible that men wit

CYP17 MspA1 polymorphism and risk of bil
CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: A population-based study in Shanghai, China
✍ Lifang Hou; Jianfeng Xu; Yu-Tang Gao; Asif Rashid; Síqun Lilly Zheng; Lori C. Sa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 102 KB 👁 2 views

## Abstract Biliary tract cancers, encompassing cancers of the gallbladder, extrahepatic bile duct and ampulla of Vater, are rare but highly fatal malignancies. Other than gallstones, little is known about the risk factors for biliary tract cancers. Endogenous estrogens are thought to play a role i

Polymorphisms of fibroblast growth facto
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population
✍ Zhiyong Ma; Norihiko Tsuchiya; Takeshi Yuasa; Takamitsu Inoue; Teruaki Kumazawa; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB

## Abstract Fibroblast growth factor receptor 4 (FGFR4) is a member of a family of transmembrane receptors with ligand‐induced tyrosine kinase activity. The Glycine (Gly) to Arginine (Arg) polymorphism at codon 388 (Gly388Arg), which encodes an amino acid in the transmembrane part of the FGFR4 gene

Recreational physical activity and risk
Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study)
✍ Tom I.L. Nilsen; Pål R. Romundstad; Lars J. Vatten 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 86 KB 👁 2 views

## Abstract Physical activity has been studied in relation to prostate cancer risk, but the findings have been inconclusive. We prospectively examined the association between self‐reported recreational physical activity and overall risk of prostate cancer, risk of advanced disease and risk of prost

Serum linoleic and total polyunsaturated
Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: A population-based cohort study
✍ David E. Laaksonen; Jari A. Laukkanen; Leo Niskanen; Kristiina Nyyssönen; Tiina 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 94 KB

## Abstract Dietary and serum fatty acid composition has been implicated in the pathogenesis of prostate and other cancers, but findings have been conflicting. Cohort studies reporting serum fatty acid composition are lacking. We assessed the association of fatty acid composition determined from di

Biliary tract cancer and stones in relat
Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China
✍ Ann W. Hsing; Yu-Tang Gao; Katherine A. McGlynn; Shelley Niwa; Mingdong Zhang; T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 82 KB 👁 1 views

## Abstract Biliary tract cancers are relatively rare but fatal tumors. Apart from a close link with gallstones and cholangitis, risk factors for biliary tract cancer are obscure. Chronic liver conditions, including liver cirrhosis, have been linked to a higher risk of biliary tract cancer. In a po